These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2788271)

  • 21. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
    Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
    Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
    Friedman DI; Amidon GL
    Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan as a novel nasal delivery system for peptide drugs.
    Illum L; Farraj NF; Davis SS
    Pharm Res; 1994 Aug; 11(8):1186-9. PubMed ID: 7971722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
    Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
    Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.
    Cros CD; Toth I; Blanchfield JT
    Bioorg Med Chem; 2011 Feb; 19(4):1528-34. PubMed ID: 21273080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.
    Kerchner GA; Geary LE
    J Pharmacol Exp Ther; 1983 Jul; 226(1):33-8. PubMed ID: 6345754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
    Beliaev NA; Kolesanova EF; Kelesheva LF; Rotanova TV; Panchenko LF
    Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of nasal absorption of drugs. IV: Plasma levels of radioactivity following intranasal administration of [3H]leucine enkephalin.
    Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
    J Pharm Sci; 1990 Sep; 79(9):768-70. PubMed ID: 2273455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
    Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
    J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro evaluation of metabolism and poor membrane permeation impeding intestinal absorption of leucine enkephalin, and methods to increase absorption.
    Aungst BJ; Blake JA; Hussain MA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):139-45. PubMed ID: 1920113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms protecting plasma peptides from enzyme hydrolysis: a comparative study.
    Venturelli F; Roscetti G; Roda LG
    Comp Biochem Physiol B; 1987; 87(3):485-8. PubMed ID: 3621910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
    Shimamura M; Hazato T; Hachisu M; Katayama T
    J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.
    Tengamnuay P; Mitra AK
    Pharm Res; 1990 Apr; 7(4):370-5. PubMed ID: 2194199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside.
    Arnold JJ; Fyrberg MD; Meezan E; Pillion DJ
    J Pharm Sci; 2010 Apr; 99(4):1912-20. PubMed ID: 19894270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
    Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
    Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.
    Agu RU; Vu Dang H; Jorissen M; Kinget R; Verbeke N
    Peptides; 2004 Apr; 25(4):563-9. PubMed ID: 15165710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
    Mosnaim AD; Puente J; Saavedra R; Diamond S; Wolf ME
    Pharmacology; 2003 Jan; 67(1):6-13. PubMed ID: 12444298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases.
    Kashi SD; Lee VH
    Life Sci; 1986 Jun; 38(22):2019-28. PubMed ID: 3713436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
    Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
    Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.